Gastrointestinal Cancer News

Adults with type 2 diabetes are more likely to develop cancer, particularly in the pancreas, thyroid, liver, lungs, stomach and colon, according to findings published in the Journal of Diabetes.

PHILADELPHIA — Effectively treating solid epithelial cancers will require targeting a patient’s somatic cancer mutations, leading to highly complex, individualized treatments, according to Steven A. Rosenberg, MD, PhD, chief of surgery at the NCI.

Patients who cannot undergo surgery for early gastric cancers could benefit from local disease control with endoscopic submucosal dissection, according to study results.

Patients with inflammatory bowel disease-associated colorectal cancer appeared to have worse survival than patients with sporadic CRC, mostly due to survival differences among younger patients, according to study results.

The FDA approved ramucirumab as single-agent therapy for certain patients with hepatocellular carcinoma.

Pancreatic ductal adenocarcinoma, or PDAC, is the third most common cause of cancer-related death in the United States, with a median 5-year survival rate of only 9%.

Patients with hepatocellular carcinoma and portal vein invasion achieved longer OS with the addition of hepatic arterial cell infusion of FOLFOX to sorafenib, according to results of a randomized phase 3 study published in JAMA Oncology.

Circulating tumor DNA levels detected disease recurrence earlier than conventional postoperative surveillance among patients with resected colorectal cancer, according to results of a retrospective study published in JAMA Oncology.

Nonoperative “watch-and-wait” management may be a viable strategy for certain patients with rectal cancer who demonstrate a complete clinical response to neoadjuvant therapy, according to study results published in Surgical Oncology.

A single dose of aspirin did not help improve the sensitivity of fecal immunochemical testing for adults undergoing colorectal cancer screening, according to a study published in JAMA.